SMSPHARMA

Sms Pharmaceuticals Share PriceSMS Pharmaceuticals

₹58.25
1.75 (3.1%)
As on 31 March, 2023 | 21:23 BSE: 532815 NSE: SMSPHARMA

Sms Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in SMS Pharmaceuticals

Start SIP

Sms Pharmaceuticals Share Price

  • Over 1 Month -15.27%
  • Over 3 Month -29.65%
  • Over 6 Month -33.96%
  • Over 1 Year -37.7%

Sms Pharmaceuticals Key Statistics

P/E Ratio -101.9
PEG Ratio 1
Market Cap Cr 493
Price to Book Ratio 1
EPS 8
Dividend 0.5
Relative Strength Index 29.54
Money Flow Index 35.53
MACD Signal -2.76
Average True Range 3.28

Sms Pharmaceuticals Investment Rating

  • Master Rating:
  • Sms Pharmaceuticals has an operating revenue of Rs. 433.54 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 13% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

SMS Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 1491596461
Operating Expenses Qtr Cr 1311466565
Operating Profit Qtr Cr 18140-4
Depreciation Qtr Cr 8888
Interest Qtr Cr 6554
Tax Qtr Cr 10-3-25
Net Profit Qtr Cr 51-109

Sms Pharmaceuticals Technicals

EMA & SMA

Current Price
₹58.25
1.75 (3.1%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 63.8
  • 50 Day
  • 69.2
  • 100 Day
  • 74.64
  • 200 Day
  • 82.56
  • 20 Day
  • 64.89
  • 50 Day
  • 69.98
  • 100 Day
  • 77.09
  • 200 Day
  • 80.99

Sms Pharmaceuticals Resistance and Support

PIVOT
₹56.49
Resistance
First Resistance 58.22
Second Resistance 59.94
Third Resistance 61.67
RSI 29.54
MFI 35.53
MACD Single Line -2.76
MACD -3.51
Support
First Resistance 54.77
Second Resistance 53.04
Third Resistance 51.32

Sms Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 162,450 11,135,948 68.55
Week 123,319 7,685,209 62.32
1 Month 91,544 7,374,765 80.56
6 Month 74,281 4,688,600 63.12

Sms Pharmaceuticals Result Highlights

SMS Pharmaceuticals Synopsis

NSE-Medical-Generic Drugs

Sms Pharmaceuticals is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 519.87 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2022. SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066.
Market Cap 493
Sales 434
Shares in Float 3.05
No of funds 3
Yield 0.53
Book Value 0.99
U/D Vol ratio 0.6
LTDebt / Equity 30
Alpha -0.16
Beta 0.9

SMS Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 64.17%64.17%64.17%
Mutual Funds
Foreign Portfolio Investors 0.59%0.59%0.63%
Individual Investors 28.82%28.84%29.65%
Others 6.42%6.4%5.55%

SMS Pharmaceuticals Management

Name Designation
Mr. Ramesh Babu Potluri Chairman & Managing Director
Mr. Vamsi Krishna Potluri Executive Director
Mr. Sarath Kumar Pakalapati Independent Director
Mr. Sharvan Kudaravalli Independent Director
Mr. Sarvepalli Srinivas Independent Director
Dr.(Mrs.) Neelaveni Thummala Independent Director

Sms Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

SMS Pharmaceuticals MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

SMS Pharmaceuticals FAQs

What is Share Price of SMS Pharmaceuticals ?

SMS Pharmaceuticals share price is ₹58 As on 31 March, 2023 | 21:09

What is the Market Cap of SMS Pharmaceuticals ?

The Market Cap of SMS Pharmaceuticals is ₹493.1 Cr As on 31 March, 2023 | 21:09

What is the P/E ratio of SMS Pharmaceuticals ?

The P/E ratio of SMS Pharmaceuticals is -101.9 As on 31 March, 2023 | 21:09

What is the PB ratio of SMS Pharmaceuticals ?

The PB ratio of SMS Pharmaceuticals is 1 As on 31 March, 2023 | 21:09

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number